
It has been the aim of the present investigation to study the effect of zzso applied human zzso zzso zzso zzso 5 for the first two weeks, and zzso 3 three times a week) in a zzso clinical trial of thirteen patients with advanced head and neck zzso cell zzso All of the patients had failed established therapeutic zzso before and could not be treated by conventional zzso zzso was injected zzso and its effect on zzso size was assessed by an independent, second observer as well as via CT and MR zzso All assessments were done prior to treatment, 8 weeks after beginning treatment and at 16 zzso Three female and ten male patients with primary zzso of the zzso zzso zzso zzso the zzso zzso zzso zzso the zzso zzso zzso 1), the zzso zzso zzso zzso 1), the oral cavity zzso zzso 1) and the zzso zzso zzso 1) have undergone zzso treatment three times a zzso zzso size showed no change in six patients while progressive disease occurred in seven cases after eight weeks of zzso zzso findings did not change in the nine patients continuing treatment while five showed progressive zzso There were no serious local or systemic side effects due to the zzso zzso zzso The survival time was zzso months after the onset of zzso zzso 

